Allstate Corporation’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,352
| Closed | -$590K | – | 222 |
|
|
2025
Q1 | $590K | Buy |
8,352
+2,758
| +49% | +$195K | 0.02% | 473 |
|
|
2024
Q4 | $368K | Buy |
+5,594
| New | +$368K | 0.01% | 551 |
|
|
2023
Q1 | – | Sell |
-5,978
| Closed | -$619K | – | 243 |
|
|
2022
Q4 | $619K | Buy |
5,978
+155
| +3% | +$16K | 0.02% | 457 |
|
|
2022
Q3 | $494K | Hold |
5,823
| – | – | 0.01% | 496 |
|
|
2022
Q2 | $483K | Sell |
5,823
-4,274
| -42% | -$355K | 0.01% | 508 |
|
|
2022
Q1 | $778K | Buy |
+10,097
| New | +$778K | 0.02% | 447 |
|
|
2020
Q3 | – | Sell |
-6,245
| Closed | -$770K | – | 669 |
|
|
2020
Q2 | $770K | Buy |
6,245
+1,982
| +46% | +$244K | 0.03% | 317 |
|
|
2020
Q1 | $360K | Buy |
+4,263
| New | +$360K | 0.01% | 441 |
|
|
2019
Q4 | – | Sell |
-32,536
| Closed | -$2.19M | – | 617 |
|
|
2019
Q3 | $2.19M | Buy |
32,536
+4,727
| +17% | +$319K | 0.04% | 275 |
|
|
2019
Q2 | $2.38M | Buy |
+27,809
| New | +$2.38M | 0.04% | 250 |
|
|
2017
Q3 | – | Sell |
-16,358
| Closed | -$1.49M | – | 61 |
|
|
2017
Q2 | $1.49M | Sell |
16,358
-11,188
| -41% | -$1.02M | 0.08% | 129 |
|
|
2017
Q1 | $2.42M | Sell |
27,546
-11,900
| -30% | -$1.04M | 0.15% | 105 |
|
|
2016
Q4 | $3.27M | Buy |
39,446
+23,121
| +142% | +$1.92M | 0.2% | 143 |
|
|
2016
Q3 | $1.51M | Buy |
+16,325
| New | +$1.51M | 0.11% | 131 |
|